logo

EW

Edwards Lifesciences·NYSE
--
--(--)
--
--(--)
8.74 / 10
Outperform

Assessment shows outstanding fundamentals at 8.7/10. Constructive elements: Profit-MV and Net income-Revenue, although drawbacks are visible in Revenue-MV and Asset-MV. Investment case: highly favorable.

Fundamental(8.74)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.86
Score0/3
Weight-14.39%
1M Return-3.20%
Annualized return on equity (%)
Value12.97
Score3/3
Weight10.64%
1M Return1.92%
Net cash flow from operating activities / Operating revenue (%)
Value25.44
Score3/3
Weight10.89%
1M Return1.92%
Profit-MV
Value0.24
Score3/3
Weight21.47%
1M Return3.80%
Net income-Revenue
Value0.50
Score2/3
Weight22.07%
1M Return3.71%
ROE (diluted) (%)
Value9.63
Score3/3
Weight10.33%
1M Return1.88%
Asset-MV
Value-0.50
Score1/3
Weight-3.27%
1M Return-0.76%
ROE (%)
Value9.72
Score3/3
Weight10.64%
1M Return1.92%
Cash-MV
Value-0.34
Score3/3
Weight21.78%
1M Return3.66%
Net profit / Total profit (%)
Value82.72
Score3/3
Weight9.85%
1M Return1.83%
Is EW fundamentally strong?
  • EW scores 8.74/10 on fundamentals and holds a Discounted valuation at present. Backed by its 9.69% ROE, 23.16% net margin, 33.78 P/E ratio, 4.53 P/B ratio, and -66.04% earnings growth, these metrics solidify its Outperform investment rating.